Clinical development services company

Company to buy

• Size: medium-sized business
• Revenue: 3-30 M EUR
• Location of the target company: Europe
• Reason for acquisition: The company is interested in acquiring CRO, more specifically Clinical Development Services company in Europe.
• #CFIEPHB027 

Overview of this buyer for CRO unit 

This buyer would like to acquire a clinical development services company that operates in Europe and has a revenue between 3-30 million euro. 

Profile (strategy) of the CRO buyer   

A leading global contract research and manufacturing organization that is based in Asia.

Focusing on end-to-end discovery, development and manufacturing services for chemical entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health,

Another activity that the company operates: drug discovery, development and capabilities in medicinal chemistry, biology, pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing.

The company is fully certified: ISO, OHSAS, GLP and AAALAC. 

Activities and products of the target CRO unit 

The goal of the buyer is to acquire a contract research organization, CRO, more specifically clinical development services company in Europe.

It should have a good vision and all the necessary GMP compliance with the scope of modification and a yearly turnover between Euro 3-30 million euro. 

Highlights of the CRO buyer 

• An internationally and publicly owned company that is based in Asia. 
• Looking for clinical development services company in Europe.
• Searching for a stable company that provides support for the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.
• The target should be a contract research company with the revenue between (3 – 30 million euro).

Information about this CRO unit

Feel free to contact us for more information regarding this CRO unit wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.